Skip to main content

Table 4 Direct, indirect, total indirect, and total effects of child mediators on maternal metabolic syndrome (MetS) on child outcomes (adjusted model)

From: Maternal metabolic syndrome in pregnancy and child development at age 5: exploring mediating mechanisms using cord blood markers

(a) MetS on

DE

DE 95% CI

IE

IE 95% CI

T-IE

T-IE 95% CI

TE

TE 95% CI

BPVS (n = 13,812)

.000

 − .033 to .036

  

 − .004

 − .012 to .004

 − .004

 − .036 to .031

    (a) Triglycerides

 − .039

 − .093 to .000

.000

 − .006 to .002

    (b) Triglycerides

.010

 − .057 to .083

  

    (a) HDL

 − .088***

 − .124 to − .048

 − .005

 − .014 to .002

    (b) HDL

.056

 − .028 to .139

  

    (a) LDL

 − .002

 − .049 to .040

0.00

 − .002 to .003

    (b) LDL

 − 0.30

 − .105 to .042

  

    (a) Adiponectin

 − .019

 − .067 to .033

0.00

 − .001 to .005

    (b) Adiponectin

 − .021

 − .083 to .040

  

    (a) Leptin

 − .054**

 − .098 to − .026

.001

 − .036 to .031

    (b) Leptin

 − .014

 − .055 to .051

  

LID (n = 13,812)

.010

 − .031 to .046

  

.003

 − .003 to .012

.014

 − .026 to .047

    (a) Triglycerides

 − .039

 − .092 to − .001

.000

 − .004 to .003

    (b) Triglycerides

.000

 − .074 to .065

  

    (a) HDL

 − .086***

 − .121 to − .046

.003

 − .003 to .011

    (b) HDL

 − .036

 − .109 to .036

  

    (a) LDL

 − .004

 − .051 to .039

.000

 − .003 to .005

    (b) LDL

 − .064

 − .138 to − .009

  

    (a) Adiponectin

 − .020

 − .066 to 0.33

.000

 − .004 to .001

    (b) Adiponectin

.008

 − .060 to .068

  

    (a) Leptin

 − .054**

 − .098 to − .026

.000

 − .002 to .002

    (b) Leptin

 − .005

 − .042 to .060

  

COM (n = 13,832)

 − .011

 − .032 to .012

  

 − .007*

 − .014 to − .001

 − .018

 − .038 to .004

    (a) Triglycerides

 − .040

 − .092 to .004

 − .001

 − .006 to .001

    (b) Triglycerides

.025

 − .025 to .076

  

    (a) HDL

 − .086***

 − .121 to − .046

 − .005

 − .012 to .000

    (b) HDL

.059

.002 to .118

  

    (a) LDL

 − .004

 − .051 to .040

.000

 − .003 to .002

    (b) LDL

.035

 − .025 to .076

  

    (a) Adiponectin

 − .020

 − .072 to .028

.001

 − .001 to .004

    (b) Adiponectin

 − .032

 − .081 to .018

  

    (a) Leptin

 − .054**

 − .097 to − .027

 − .001

 − .003 to .000

    (b) Leptin

.019

 − .010 to .055

  

PSE (n = 13,832)

 − .007

 − .027 to .016

  

 − .006*

 − .013 to − .001

 − .013

 − .032 to .007

    (a) Triglycerides

 − .040

 − .092 to .004

 − .001

 − .005 to .001

    (b) Triglycerides

.018

 − .030 to .063

  

    (a) HDL

 − .087***

 − .121 to − .047

 − .005

 − .013 to − .001

    (b) HDL

.062

.003 to .120

  

    (a) LDL

 − .004

 − .051 to .040

.000

 − .003 to .001

    (b) LDL

.032

 − .023 to .085

  

    (a) Adiponectin

 − .019

 − .072 to .026

.000

 − .001 to .004

    (b) Adiponectin

 − .023

 − .069 to .029

  

    (a) Leptin

 − .054**

 − .097 to − .027

.000

 − .032 to .002

    (b) Leptin

.003

 − .025 to .039

  

PHY (n = 13,832)

 − .011

 − .032 to .011

  

 − .005

 − .012 to .000

 − .015

 − .036 to − .005

    (a) Triglycerides

 − .039

 − .091 to .004

 − .000

 − .003 to .002

    (b) Triglycerides

.002

 − .045 to .050

  

    (a) HDL

 − .087***

 − .121 to − .046

 − .005

 − .011 to − .000

    (b) HDL

.054

 − .001 to .111

  

    (a) LDL

 − .004

 − .050 to .041

.000

 − .003 to .001

    (b) LDL

.027

 − .026 to .079

  

    (a) Adiponectin

 − .019

 − .071 to .029

.001

 − .001 to .004

    (b) Adiponectin

 − .036

 − .085 to .011

  

    (a) Leptin

 − .054**

 − .097 to − .027

 − .001

 − .003 to .001

    (b) Leptin

.010

 − .019 to .043

  

LIT (n = 13,832)

 − .025*

 − .045 to − .005

  

 − .005

 − .011 to .000

 − .030**

 − .051 to − .010

    (a) Triglycerides

 − .040

 − .092 to .004

 − .001

 − .005 to .001

    (b) Triglycerides

.020

 − .029 to .067

  

    (a) HDL

 − .086***

 − .121 to − .046

 − .004

 − .010 to .001

    (b) HDL

.042

 − .010 to .099

  

    (a) LDL

 − .004

 − .052 to .040

.000

 − .003 to .001

    (b) LDL

.033

 − .019 to .084

  

    (a) Adiponectin

 − .020

 − .070 to .027

.000

 − .001 to .003

    (b) Adiponectin

 − .019

 − .067 to .031

  

    (a) Leptin

 − .054**

 − .097 to − .026

 − .001

 − .003 to .000

    (b) Leptin

.019

 − .009 to .055

  

MAT (n = 13,832)

 − .015

 − .035 to .008

  

 − .005

 − .012 to .000

 − .020

 − .040 to .001

    (a) Triglycerides

 − .040

 − .092 to .004

 − .002

 − .006 to .000

    (b) Triglycerides

.039

 − .007 to .084

  

    (a) HDL

 − .086***

 − .121 to − .047

 − .003

 − .009 to .001

    (b) HDL

.037

 − .015 to .092

  

    (a) LDL

 − .004

 − .052 to .040

.000

 − .003 to .001

    (b) LDL

.034

 − .023 to .083

  

    (a) Adiponectin

 − .019

 − .071 to .028

.001

 − .001 to .004

    (b) Adiponectin

 − .040

 − .089 to .010

  

    (a) Leptin

 − .054**

 − .097 to − .027

 − .001

 − .004 to .000

    (b) Leptin

.026

 − .004 to .062

  
  1. Participant sample sizes ranged from 12,652 (found in unadjusted models) to 13,832 mother–child pairs depending on the availability of data
  2. DE direct effect, IE indirect effect, T-IE total indirect effect, TE total effects (direct effect + indirect effect)
  3. (a) Child mediators on METSYN; (b) child outcomes on child mediators
  4. *p < .05, **p < .01, ***p < .001